Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF, 659K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wells, W. A. Search for Related Content PubMed Articles by Wells, W. A. Social Bookmarking                            What's this?

© The Rockefeller University Press, 0021-9525/2003/5/669-a $5.00
The Journal of Cell Biology, Volume 161, Number 4, 669-a-669

Metastasizing in search of oxygen

The proinvasive effect of HGF (left) is amplified by hypoxia (right). Comoglio/Elsevier

Metastatic growth can start when suffocating tumor cells go hunting for oxygen, according to a report from Selma Pennacchietti, Paolo Michieli, Paolo Comoglio, and colleagues (University of Torino, Torino, Italy).

The response appears to be part of a normal program used to create and maintain organs—a process that uses oxygen gradients as one guiding principle. "Mother Nature has given us the invasion program not to promote metastasis but to promote sprouting and branching of epithelial tubes," says Comoglio.

In hypoxic tumor cells, his team found that binding of hypoxia inducible factor-1 (HIF-1) to two sites in the met promoter-induced expression of the Met tyrosine kinase receptor. This newly abundant Met, after the binding of ubiquitous hepatocyte growth factor (HGF, or scatter factor-1), activates an invasive migration program.

They found that Met levels were dramatically increased in the hypoxic areas of tumors, and that high levels of Met were both necessary for hypoxia-induced branching morphogenesis and sufficient to induce branching morphogenesis in normoxic conditions.

Previous workers have stressed that hypoxia induces angiogenesis and apoptosis resistance. But the new work suggests that treatment with antiangiogenic agents is too simplistic. These drugs increase hypoxia in a tumor, and may thus promote metastasis. A combination therapy that attacks both angiogenic and metastatic pathways may have a better chance of success.

Reference:

Pennacchietti, S., et al. 2003. Cancer Cell. 3:347–361.[CrossRef][Medline]

William A. Wells

wellsw{at}rockefeller.edu

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF, 659K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wells, W. A. Search for Related Content PubMed Articles by Wells, W. A. Social Bookmarking                            What's this?